In addition, it has been reported that MEK/ERK phosphorylation regulates the expression or activity of DNMT1, thereby causing DNA methylation changes that affect the expression of tumor suppressor genes in prostate cancer as well as methylation-sensitive genes associated with the pathogenesis of systemic lupus erythematosus (SLE). This evidence concerns the gene MAPK1 and prostate cancer.